Nitric Oxide-Releasing Biomaterials for Biomedical Applications

被引:57
作者
Zhou, Xin [1 ]
Zhang, Jimin [1 ]
Feng, Guowei [2 ]
Shen, Jie [3 ]
Kong, Deling [1 ]
Zhao, Qiang [1 ]
机构
[1] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ, Tianjin 300071, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Dept Genitourinary Oncol, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China
[3] Nankai Univ, Sch Pharm, Tianjin 300071, Peoples R China
关键词
Nitric oxide; Biomaterials; Controlled delivery; Biomedical applications; Cardiovascular diseases; Cancer; SITU CATALYTIC GENERATION; ANTI-BIOFILM EFFICACY; IN-STENT RESTENOSIS; COLON-CANCER CELLS; CHITOSAN OLIGOSACCHARIDES; IMPROVED HEMOCOMPATIBILITY; ACINETOBACTER-BAUMANNII; PSEUDOMONAS-AERUGINOSA; POLYMERIC COATINGS; ENDOTHELIAL-CELLS;
D O I
10.2174/0929867323666160729104647
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO), as an essential signaling molecule, participates in various physiological processes such as cardiovascular homeostasis, neuronal transmission, immunomodulation, and tumor growth. The multiple role of NO in physiology and pathophysiology has triggered a massive interest in the strategies of delivering exogenous NO for biomedical applications. Hence, different kinds of NO prodrugs have been developed up to date, including diazeniumdiolates, S-nitrosothiol, metal-nitrosyl, nitrobenzene, and so on. However, the clinical application of these low molecular weight NO donors has been restricted due to the problems of burst release, low payloads, and untargeted delivery. The delivery of NO by biomaterial-based carrier offers a beneficial strategy to realize the controlled and sustained delivery of NO to the targeted tissues or organs. In detail, NO-donor prodrugs have been attached and loaded to diverse biomaterials to fabricate nanoparticles, hydrogels, and coating platforms by means of physical, chemical, or supramolecular techniques. These NO-releasing biomaterials hold promise for a number of biomedical applications ranging from therapy of the ischemic disease and several types of cancer to cardiovascular devices and wound dressing. First, surface coating with NO-releasing biomaterials could mimic the physiological function of vascular endothelium, therefore promoting vascularization and improving the patency of cardiovascular implants. Next, because NO also mediates many important processes that take place after cutaneous injury, NO-releasing biomaterials could serve as ideal wound dressing to accelerate tissue regeneration. Finally, biomaterials enable localized delivery of high dose of NO to tumors in a sustained manner, thus generating potent tumoricidal effect. In this review, we will summarize the progress of different NO-releasing biomaterials, and highlight their biomedical applications with a hope to inspire new perspectives in the area of biomaterial-based NO-delivery systems.
引用
收藏
页码:2579 / 2601
页数:23
相关论文
共 209 条
[1]   Perivascular Nitric Oxide Delivery to Saphenous Vein Grafts Prevents Graft Stenosis after Coronary Artery Bypass Grafting: A Novel Sheep Model [J].
Abbasi, Kyomars ;
Shalileh, Keivan ;
Anvari, Maryam Sotudeh ;
Rabbani, Shahram ;
Mahdanian, Abolfazl ;
Ahmadi, Seyed Hosein ;
Moshtaghi, Naghmeh ;
Movahedi, Namvar ;
Karimi, Abbasali .
CARDIOLOGY, 2011, 118 (01) :8-15
[2]  
Adamian A A, 2004, Khirurgiia (Mosk), P10
[3]   Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes [J].
Adams, DJ ;
Levesque, MC ;
Weinberg, JB ;
Smith, KL ;
Flowers, JL ;
Moore, J ;
Colvin, OM ;
Silber, R .
LEUKEMIA, 2001, 15 (12) :1852-1859
[4]   Statins and breast cancer prognosis: evidence and opportunities [J].
Ahern, Thomas P. ;
Lash, Timothy L. ;
Damkier, Per ;
Christiansen, Peer M. ;
Cronin-Fenton, Deirdre P. .
LANCET ONCOLOGY, 2014, 15 (10) :E461-E468
[5]   The formation of an anti-restenotic/anti-thrombotic surface by immobilization of nitric oxide synthase on a metallic carrier [J].
Alagem-Shafir, M. ;
Kivovich, E. ;
Tzchori, I. ;
Lanir, N. ;
Falah, M. ;
Flugelman, M. Y. ;
Dinnar, U. ;
Beyar, R. ;
Lotan, N. ;
Sivan, S. S. .
ACTA BIOMATERIALIA, 2014, 10 (05) :2304-2312
[6]   S-nitrosoglutathione-containing hydrogel accelerates rat cutaneous wound repair [J].
Amadeu, T. P. ;
Seabra, A. B. ;
de Oliveira, M. G. ;
Costa, A. M. A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 (05) :629-637
[7]   Construction and evaluation of nitric oxide generating vascular graft material loaded with organoselenium catalyst via layer-by-layer self-assembly [J].
An Jun ;
Chen SiYuan ;
Gao JingChen ;
Zhang Xu ;
Wang YuanYuan ;
Li YanDong ;
Mikhalovsky Sergey ;
Kong DeLing ;
Wang ShuFang .
SCIENCE CHINA-LIFE SCIENCES, 2015, 58 (08) :765-772
[8]   A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants [J].
Andukuri, Adinarayana ;
Kushwaha, Meenakshi ;
Tambralli, Ajay ;
Anderson, Joel M. ;
Dean, Derrick R. ;
Berry, Joel L. ;
Sohn, Young Doug ;
Yoon, Young-Sup ;
Brott, Brigitta C. ;
Jun, Ho-Wook .
ACTA BIOMATERIALIA, 2011, 7 (01) :225-233
[9]   Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers [J].
Annich, GM ;
Meinhardt, JP ;
Mowery, KA ;
Ashton, BA ;
Merz, SI ;
Hirschl, RB ;
Meyerhoff, ME ;
Bartlett, RH .
CRITICAL CARE MEDICINE, 2000, 28 (04) :915-920
[10]   Anti-biofilm action of nitric oxide-releasing alkyl-modified poly(amidoamine) dendrimers against Streptococcus mutans [J].
Backlund, Christopher J. ;
Worley, Brittany V. ;
Schoenfisch, Mark H. .
ACTA BIOMATERIALIA, 2016, 29 :198-205